Disease and mortality in Sub-Saharan Africa

Select an Action

Title:

Author:

Jamison, Dean T.

ISBN:

9780821363973

9780821363980

Edition:

2nd ed.

Publication Information:

Washington, D.C. : World Bank, c2006.

Physical Description:

xxii, 387 p. : ill., maps ; 29 cm.

Contents:

Changing patterns of disease and mortality in Sub-Saharan Africa: an overview / Levels and trends in mortality in Sub-Saharan Africa: an overview / Trends in child mortality, 1960 to 2000 / Levels and trends of adult mortality / Causes of death / Population and mortality after AIDS / Levels and patterns of mortality at INDEPTH demographic surveillance systems / Trends and issues in child undernutrition / Diarrheal diseases / Developmental disabilities / Acute respiratory infections / Vaccine-preventable diseases / Tuberculosis / Malaria / Onchocerciasis / Maternal mortality / HIV/AIDS / Lifestyle and related risk factors for chronic diseases / Diabetes mellitus / Cancers / Cardiovascular disease / Mental health and the abuse of alcohol and controlled substances / Neurological disorders / Violence and injuries

Subject Term:

Public health -- Africa, Sub-Saharan.

Mortality -- Africa South of the Sahara -- Statistics.

Health Status Indicators -- Africa South of the Sahara -- Statistics.

Health Surveys -- Africa South of the Sahara -- Statistics.

Morbidity -- Africa South of the Sahara -- Statistics.

Public Health -- statistics & numerical data -- Africa South of the Sahara.

Added Author:

Jamison, Dean T.

Added Corporate Author:

World Bank.

Electronic Access:

Table of contents only http://www.loc.gov/catdir/toc/fy0702/2006283519.html

Copies:

Available:*

Library	Material Type	Item Barcode	Shelf Number	Copy	Status
Searching... IIEMSA	General Books	33168020385403	362.10967 J32D 2006	1	Searching... Unknown

Bound With These Titles

On Order

Summary

Current data and trends in morbidity and mortality for the sub-Saharan Region as presented in this new edition reflect the heavy toll that HIV/AIDS has had on health indicators, leading to either a stalling or reversal of the gains made, not just for communicable disorders, but for cancers, as well as mental and neurological disorders.